Title:
トランスグルタミナーゼ２（ＴＧ２）阻害剤
Document Type and Number:
Japanese Patent JP7433315
Kind Code:
B2
Abstract:
Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit transglutaminase 2 (TG2). Also described herein are methods for using such TG2 inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from TG2 inhibition.
Inventors:
David, Campbell
Justin, Chapman
Mui, H. Chun
Thomas, Earl Delymond
Sergio, Gee Duron
Justin, Chapman
Mui, H. Chun
Thomas, Earl Delymond
Sergio, Gee Duron
Application Number:
JP2021531468A
Publication Date:
February 19, 2024
Filing Date:
August 09, 2019
Export Citation:
Assignee:
SITARI PHARMA, INC.
International Classes:
C07D401/06; A61K31/4439; A61K31/444; A61K31/506; A61K31/52; A61P25/00; A61P25/14; A61P25/28; A61P27/02; A61P27/06; A61P27/12; A61P35/00; A61P37/06; A61P43/00; C07D401/14; C07D403/06; C07D405/14; C07D413/06; C07D413/14; C07D417/06; C07D417/14; C07D471/04; C07D473/00; C07D473/30; C07D473/34; C07D487/04
Domestic Patent References:
| JP2010509195A | ||||
| JP2015509645A |
Foreign References:
| US20120302539 |
Attorney, Agent or Firm:
Yukitaka Nakamura
Manabu Miyajima
Mari Asano
Keiyasu Suzuki
Manabu Miyajima
Mari Asano
Keiyasu Suzuki